 VANCOUVER, British Columbia SEATTLE--BUSINESS WIRE--Zymeworks Inc. NYSE: ZYME, a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will participate in upcoming investor conferences. Guggenheim Oncology Conference 2022. Zymeworks will participate virtually in one-on-one meetings and a fireside chat on February 9th at 1:00 p.m. ET. 11th Annual SVB Leerink Global Healthcare Conference. Zymeworks will participate virtually in 